Subscribe to MDT Magazine News

BBA partners with Ireland's Creganna in joint venture

February 10, 2011 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Northborough-based Boston Biomedical Associates LLC has entered into a joint venture with Irish firm Creganna-Tactx Medical, giving the Galway-based company's customers access to BBA's clinical, regulatory and quality expertise and consulting services.


Parents, Physicians Unite and Declare: State of Emergency

February 10, 2011 9:35 am | by Bio-Medicine.Org | Comments

BRADENTON, Fla., Feb. 10, 2011 /- 'We are in a State of Emergency at the hands of prescription drugs.'  That is the message that concerned Florida residents are desperate for people to hear. Floridians are dying at a rate of at least 7 per day due to prescription drug abuse and...


ZONARE Provides Ultrasound System for Medical Missions to Guatemala

February 10, 2011 9:34 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Feb. 10, 2011 /- ZONARE Medical Systems, Inc., a developer of high-end ultrasound solutions, loaned a Ultrasound System to Woodlands Church of Plover, WI, for use on medical missions to Sumpango, Guatemala.  Over the past year, ZONARE has provided six...


Susan Band Horwitz, Ph.D., Receives AACR Award for Lifetime Achievement in Cancer Research

February 10, 2011 9:33 am | by AACR | Comments

ORLANDO, Fla. - Susan Band Horwitz, Ph.D., will receive the Eighth AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel (Taxol), which prompted the development of this...


Noveko International shrinks its Q2 losses on higher sales during H1N1 crisis

February 10, 2011 8:45 am | by The Associated Press | Comments

Noveko International Inc. (TSX:EKO) says the H1N1 flu crisis last year helped shrink its second-quarter net loss this year to $2.93 million.The maker of antimicrobial face masks cut its loss to three cents per share from seven cents or $5.01 million the year-earlier quarter.Noveko said sales of...

Research Team Honored for Innovative Science to Advance Cancer Research

February 10, 2011 6:33 am | by AACR | Comments

ORLANDO, Fla. - The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human...


UnitedHealth board declares 12.5-cent dividend

February 10, 2011 5:45 am | by The Associated Press | Comments

Health insurer UnitedHealth Group Inc. said Thursday that its board of directors approved a regular quarterly dividend of 12.5 cents.The dividend will be paid on March 21 to shareholders as of March 7.

UnitedHealth names Lawson to board

February 10, 2011 5:45 am | by The Associated Press | Comments

The former and CEO of Fidelity Investments has joined the board at UnitedHealth Group Inc., the company said Thursday.Prior to joining Fidelity in 2007, Rodger A. Lawson was vice chairman of Prudential Financial.Lawson will stand for re-election by shareholders at the 2011 annual meeting along...


CHAMPION Study Published in The Lancet

February 10, 2011 5:34 am | by Bio-Medicine.Org | Comments

ATLANTA, Feb. 10, 2011 /- The CHAMPION ( C ardioMEMS H eart Sensor A llows M onitoring of P ressure to I mprove O utcomes in N YHA Class III Patients) clinical trial was published online today in The Lancet . CHAMPION demonstrated a 30% reduction in the primary efficacy endpoint of heart...


New & #8216;Better By Nature & #8217; Detox Plan Promotes Health And Well-Being To Give Spring-time Feel Good Factor

February 10, 2011 4:32 am | by RealWire | Comments

"8 Weeks to a Better You" Optimum Health Plan combines detox and support for specific well-being issues using new synergistic homeopathic remediesBetter by Nature, the Stratford-On-Avon based health and well-being company, specialises in holistic homeopathic remedies based on creating...


Alexion buys IP from German biotech for infant disorder

February 10, 2011 3:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Alexion Pharmaceuticals Inc. acquired patents and assets for a possible therapy for a ultra-rare genetic disorder for $3 million in cash from Germany-based Orphatec Pharmaceuticals GmbH.


Functional Technologies Receives FDA "No Questions" Letter on GRAS Status of Hydrogen Sulphide-Reducing Yeast

February 10, 2011 2:45 am | by The Associated Press | Comments () —Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today announced that the U.S. Food and Drug Administration (FDA) has reviewed, and issued a "no questions" letter in response to, the Generally Recognized as Safe (GRAS) notification for the...

Stereotaxis to Report Fourth Quarter and Full Year 2010 Financial Results and Conduct Conference Call on February 28, 2011

February 10, 2011 2:35 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Feb. 10, 2011 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2010 on Monday, February 28, 2011 after the close of the U.S. financial markets. The Company will host a conference...


Covidien Receives FDA Approval for Fentanyl Transdermal System Patch

February 10, 2011 2:33 am | by Covidien | Comments

ST. LOUIS, Feb 10, 2011 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for...


Tegal sells DRIE assets to SPTS

February 9, 2011 11:37 pm | by I-Micronews | Comments

Tegal?s focus now exclusively on Green Energy.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.